A

Amneal Intermediate Inc
NASDAQ:AMRX

Watchlist Manager
Amneal Intermediate Inc
NASDAQ:AMRX
Watchlist
Price: 8.47 USD -1.17% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
Amneal Intermediate Inc?
Write Note

Amneal Intermediate Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amneal Intermediate Inc
Capital Expenditures Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
A
Amneal Intermediate Inc
NASDAQ:AMRX
Capital Expenditures
-$69.2m
CAGR 3-Years
-1%
CAGR 5-Years
7%
CAGR 10-Years
-4%
Johnson & Johnson
NYSE:JNJ
Capital Expenditures
-$4.4B
CAGR 3-Years
-7%
CAGR 5-Years
-4%
CAGR 10-Years
-2%
Bristol-Myers Squibb Co
NYSE:BMY
Capital Expenditures
-$1.2B
CAGR 3-Years
-14%
CAGR 5-Years
-6%
CAGR 10-Years
-8%
Pfizer Inc
NYSE:PFE
Capital Expenditures
-$3.2B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
-7%
Merck & Co Inc
NYSE:MRK
Capital Expenditures
-$3.5B
CAGR 3-Years
11%
CAGR 5-Years
-4%
CAGR 10-Years
-11%
Eli Lilly and Co
NYSE:LLY
Capital Expenditures
-$8.1B
CAGR 3-Years
-53%
CAGR 5-Years
-38%
CAGR 10-Years
-20%

See Also

What is Amneal Intermediate Inc's Capital Expenditures?
Capital Expenditures
-69.2m USD

Based on the financial report for Dec 31, 2023, Amneal Intermediate Inc's Capital Expenditures amounts to -69.2m USD.

What is Amneal Intermediate Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-4%

Over the last year, the Capital Expenditures growth was 24%. The average annual Capital Expenditures growth rates for Amneal Intermediate Inc have been -1% over the past three years , 7% over the past five years , and -4% over the past ten years .

Back to Top